Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Rhea-AI Summary

Lantheus Holdings (NASDAQ: LNTH), a leading radiopharmaceutical company, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. CEO Brian Markison will present on Wednesday, September 4, at 7:45 a.m. ET.

Investors and interested parties can access a live webcast of the presentation through the Investors section of Lantheus' website at www.lantheus.com. The company will make a replay of the webcast available on its website for at least 30 days following the live presentation.

This conference participation underscores Lantheus' commitment to engaging with the investment community and sharing insights into its business focused on enabling clinicians to Find, Fight and Follow disease for improved patient outcomes.

News Market Reaction – LNTH

+0.51%

+0.51% Session move

In the trading session that priced this news, LNTH gained 0.51%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEDFORD, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison, Chief Executive Officer, will present at the Morgan Stanley 22^nd Annual Global Healthcare Conference at 7:45 a.m. ET on Wednesday, September 4.

To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.

About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.

Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com

Melissa Downs
Senior Director, External Communications
646-975-2533
media@lantheus.com

FAQ

When is Lantheus (LNTH) presenting at the Morgan Stanley Healthcare Conference?

Lantheus (LNTH) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, at 7:45 a.m. ET.

Who will be representing Lantheus (LNTH) at the Morgan Stanley Healthcare Conference?

Brian Markison, the Chief Executive Officer of Lantheus (LNTH), will be presenting at the conference.

How can investors access Lantheus' (LNTH) presentation at the Morgan Stanley conference?

Investors can access a live webcast of Lantheus' (LNTH) presentation through the Investors section of the company's website at www.lantheus.com.

For how long will the replay of Lantheus' (LNTH) presentation be available?

A replay of Lantheus' (LNTH) presentation webcast will be available on the company's website for at least 30 days following the live presentation.

What is Lantheus' (LNTH) main focus as a company?

Lantheus (LNTH) is the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes.